Global EditionPremium world briefings with timeline, impact, and future-watch analysis.
‘Who knows what they’re taking?’: people risk the gray market for the newest weight-loss drug
HealthThe Guardian01 Sept, 04:45 amAtlasHour
Health

‘Who knows what they’re taking?’: people risk the gray market for the newest weight-loss drug

Retatrutide, not yet approved by the FDA, is the latest wonder drug to shed pounds despite warnings from doctors About two years ago, Henry, who is 6ft 3in, weighed 210lb, which meant he was only slightly overweight, according to the Centers for Disease Control and Prevention body mass index. Still, the thirtysomething who lives in the Pacific north-west had hypertension, sleep apnea and body image issues, so he started taking the weight-loss drug Ozempic. While he dropped pounds, he experienced constipation, a common side-effect, so he wanted to try retatrutide, another peptide which not only targets GLP-1 but two other hormone receptors as well...

Source-linkedAtlasHour DeskThe Guardian01 Sept, 04:45 am

What happened

Retatrutide, not yet approved by the FDA, is the latest wonder drug to shed pounds despite warnings from doctors About two years ago, Henry, who is 6ft 3in, weighed 210lb, which meant he was only slightly overweight, according to the Centers for Disease Control and Prevention body mass index.

Why it matters

AtlasHour context: this story may affect public policy, global affairs, business confidence, technology direction, energy security, or civic life.

Global context

The story is being tracked through Global Markets.

Who is affected

Global Markets

What to watch next

Readers should watch official responses, local reaction, source updates, and whether the story changes the next decision cycle.

Read the original source
Why It Matters

The consequence layer

AtlasHour context: this story may affect public policy, global affairs, business confidence, technology direction, energy security, or civic life.

Watch Next

What To Watch Next

Key Facts

Three facts to keep in view

1Source

The Guardian

1 min readRead time

Designed for a concise world-news brief.

1Context tags

Used for editorial story mapping and source context.

Read Next

Related Stories

AtlasHour updates articles as new verified information becomes available. Corrections and source context can be sent to the newsroom.